---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-057985"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:51:08.406454+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences appoints Liselotte Hyveled to Board, effective May 6

## Summary
- Board size increased to ten directors; Hyveled appointed as Class I director, term expiring at 2024 annual meeting.
- Annual cash retainer of $50,000 for Board service; grant of option to purchase 35,000 shares vesting over three years.
- Additional $7,500 annual retainer for each of Nominating Committee and Science & Technology Committee membership.
- No arrangements or transactions requiring disclosure under Item 404(a); standard indemnity agreement entered.

## SEC filing metadata
- accession: 0001104659-24-057985
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/0001104659-24-057985-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/tm2413673d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-057985
- JSON: https://secwatch.observer/filing/0001104659-24-057985.json
- Plain text: https://secwatch.observer/filing/0001104659-24-057985.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.